Location History:
- Creteil, FR (2014 - 2015)
- Paris, FR (2021 - 2023)
Company Filing History:
3 out of 1,746 
1 out of 1 
1 out of 154 
Years Active: 2014-2023
Title: Nicolae Ghinea: Innovator in Cancer Treatment
Introduction
Nicolae Ghinea is a prominent inventor based in Créteil, France. He has made significant contributions to the field of medical technology, particularly in the development of antibodies for cancer treatment. With a total of 4 patents, Ghinea's work focuses on innovative solutions that address critical health challenges.
Latest Patents
One of Ghinea's latest patents is titled "Antibodies against the human FSHR extracellular domain." This invention relates to anti-human follicle-stimulating hormone receptor antibodies, which are crucial in the treatment of cancer. The patent also outlines processes for detecting cancerous cells and diagnosing cancer, showcasing its application in therapeutic and diagnostic medical fields. Another notable patent is "Human follicle-stimulating hormone receptor (FSHR) extracellular domain antibodies and methods of use thereof," which shares similar objectives and applications in cancer treatment.
Career Highlights
Throughout his career, Nicolae Ghinea has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and FSHR Theranostics SAS. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Ghinea has collaborated with various professionals in his field, including his coworker Aurelian Radu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Nicolae Ghinea's contributions to cancer treatment through his innovative patents highlight his dedication to improving medical technology. His work continues to inspire advancements in therapeutic and diagnostic applications, making a lasting impact on healthcare.